Akamai Technologies -11.5%; reiterated neutrally at Morgan Stanley and RBC Capital Markets, bullishly at JMP Securities

• Morgan Stanley, reducing target from $70 to $68, retains Akamai Technologies at Equal Weight. Notes: "With revenue growth just beginning to inflect upwards, AKAM embarking on another investment cycle comes as a surprise to investors. A broader enterprise portfolio expands the TAM and could add stability to growth longer-term, however, shares look fully priced given near-term EPS growth."
• RBC Capital Markets, reissuing a Sector Perform rating and lowering target from $67 to $65, considers EBITDA margin outlook (high-30% vs. approximately 40% anticipated; a theme across sector) a negative among otherwise consistent fundamentals.
• Highlighting Akamai Technologies' strong Q4 while also noting negative sentiment involving expected adjusted EBITDA margin, JMP Securities reiterates at Outperform and increases target from $73 to $77.
• Akamai Technologies (NASDAQ:AKAM) $62.93.
• Previously (February 7, 2017): Akamai Technologies +1.38%; Q4 2016 above expectations
• Earnings call transcript